| Angela J Hornak, ANP-BC,FNP-BC,DNP | |
|
1350 Chester Blvd Ste B, Richmond, IN 47374-1962 | |
| (765) 935-4088 | |
| (765) 966-2596 |
| Full Name | Angela J Hornak |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 14 Years |
| Location | 1350 Chester Blvd Ste B, Richmond, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083835334 | NPI | - | NPPES |
| 000000681778 | Other | ANTHEM | |
| 200996510 | Medicaid | IN | |
| 0067475 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 71001941A (Indiana) | Secondary |
| 363LA2200X | Nurse Practitioner - Adult Health | 71001941A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Reid-anc Home Care Services Llc | Richmond, IN | Home health agency |
| Reid Hospital & Health Care Services | Richmond, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cutting Edge Physical Therapy Limited Partnership | 6406869163 | 35 |
| Reid Physician Associates, Inc. | 6406910769 | 338 |
News Archive
The range of adult primary immune deficiencies is considerable and the majority of patients are diagnosed only after specialist referral, conclude Canadian scientists who identified two novel patient groups with humoral abnormalities.
Trovagene, Inc., today announced the commercial availability of its urine-based HPV-HR (high-risk) assay, a molecular human papillomavirus test.
Edge Therapeutics, a clinical-stage biotechnology company that discovers, develops and seeks to commercialize novel, hospital-based therapies for acute, life-threatening neurological conditions, today announced that it has initiated patient enrollment in the second cohort of the NEWTON study, a multicenter, randomized, controlled, open-label, Phase 1/2 clinical trial of the company's lead product candidate, EG-1962.
DSM, which created and manufactures Dyneema Purity, the world's strongest Medical grade fiber, today announced agreements with Biomedical Structures, Cortland Company and Secant Medical. These companies' experience in processing Dyneema Purity fiber in biomedical textile structures offers medical device companies the ability to use various constructions of Dyneema Purity, including the recently launched Dyneema Purity BLUE, in commercial medical devices.
Activating a protein found on some immune cells seems to halt the cells' typical job of spewing out substances that launch allergic reactions, a study by Johns Hopkins researchers suggests.
› Verified 5 days ago
| Entity Name | Reid Physician Associates, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265689111 PECOS PAC ID: 6406910769 Enrollment ID: O20090130000573 |
News Archive
The range of adult primary immune deficiencies is considerable and the majority of patients are diagnosed only after specialist referral, conclude Canadian scientists who identified two novel patient groups with humoral abnormalities.
Trovagene, Inc., today announced the commercial availability of its urine-based HPV-HR (high-risk) assay, a molecular human papillomavirus test.
Edge Therapeutics, a clinical-stage biotechnology company that discovers, develops and seeks to commercialize novel, hospital-based therapies for acute, life-threatening neurological conditions, today announced that it has initiated patient enrollment in the second cohort of the NEWTON study, a multicenter, randomized, controlled, open-label, Phase 1/2 clinical trial of the company's lead product candidate, EG-1962.
DSM, which created and manufactures Dyneema Purity, the world's strongest Medical grade fiber, today announced agreements with Biomedical Structures, Cortland Company and Secant Medical. These companies' experience in processing Dyneema Purity fiber in biomedical textile structures offers medical device companies the ability to use various constructions of Dyneema Purity, including the recently launched Dyneema Purity BLUE, in commercial medical devices.
Activating a protein found on some immune cells seems to halt the cells' typical job of spewing out substances that launch allergic reactions, a study by Johns Hopkins researchers suggests.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Angela J Hornak, ANP-BC,FNP-BC,DNP 1100 Reid Pkwy, Medical Staff Services, Richmond, IN 47374-1157 Ph: (765) 983-3217 | Angela J Hornak, ANP-BC,FNP-BC,DNP 1350 Chester Blvd Ste B, Richmond, IN 47374-1962 Ph: (765) 935-4088 |
News Archive
The range of adult primary immune deficiencies is considerable and the majority of patients are diagnosed only after specialist referral, conclude Canadian scientists who identified two novel patient groups with humoral abnormalities.
Trovagene, Inc., today announced the commercial availability of its urine-based HPV-HR (high-risk) assay, a molecular human papillomavirus test.
Edge Therapeutics, a clinical-stage biotechnology company that discovers, develops and seeks to commercialize novel, hospital-based therapies for acute, life-threatening neurological conditions, today announced that it has initiated patient enrollment in the second cohort of the NEWTON study, a multicenter, randomized, controlled, open-label, Phase 1/2 clinical trial of the company's lead product candidate, EG-1962.
DSM, which created and manufactures Dyneema Purity, the world's strongest Medical grade fiber, today announced agreements with Biomedical Structures, Cortland Company and Secant Medical. These companies' experience in processing Dyneema Purity fiber in biomedical textile structures offers medical device companies the ability to use various constructions of Dyneema Purity, including the recently launched Dyneema Purity BLUE, in commercial medical devices.
Activating a protein found on some immune cells seems to halt the cells' typical job of spewing out substances that launch allergic reactions, a study by Johns Hopkins researchers suggests.
› Verified 5 days ago
Poshia Slusher, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3600 E Main St, Richmond, IN 47374 Phone: 765-598-5700 | |
Catherine Blyth, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1250 Chester Blvd., Suite 1, Richmond, IN 47374 Phone: 765-935-8594 Fax: 765-935-8595 | |
Mrs. Debra Kay Shaw, ANP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1301 S 8th St, Richmond, IN 47374 Phone: 765-939-3947 Fax: 765-939-3950 | |
Casey Joe Smith, FNPC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 498 Nw 18th St Ste D, Richmond, IN 47374 Phone: 765-373-8704 | |
Mrs. Britney Marie Glover, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1485 Chester Blvd., Reid Pediatric & Internal Medicine, Richmond, IN 47374 Phone: 765-966-5527 Fax: 765-966-5528 | |
Tabatha Nicole Timberman, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1050 Reid Pkwy Ste 130, Richmond, IN 47374 Phone: 765-935-8943 Fax: 765-935-8944 | |
Tina S. Chavis, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2300 Chester Blvd, Richmond, IN 47374 Phone: 765-939-2395 Fax: 765-939-2425 |